Trial Outcomes & Findings for Treating Pain in Children With Cancer: Pain Buddy (NCT NCT03384134)
NCT ID: NCT03384134
Last Updated: 2026-07-24
Results Overview
As part of the daily electronic Pain Buddy diary, children were administered the Memorial Symptoms Assessment Scale. Children 8-9 years of age received an 8-item instrument and were asked to report frequency (i.e. a very short time, a medium amount, almost all the time) severity (i.e. a little, a medium amount, very), and how distressful (i.e. not at all, a little, a medium amount, very) each symptom was. Children 10-18 years of age received a 30-item instrument and were asked to report how often (i.e. almost never, sometimes, a lot, almost always), how severe (i.e. slight, moderate, severe, very severe), and how distressful (i.e. not at all, a little bit, somewhat, quite a bit, very much) each symptom was. The items related to pain severity were used to calculate a 0-10 continuous score of self-reported pain severity for participants in each group. For this outcome, lower scores represent improvement in pain severity.
COMPLETED
NA
407 participants
Baseline and day 60
2026-07-24
Participant Flow
Children and caregivers were recruited in oncology outpatient clinics and inpatient floors at both hospitals (CHOC Children's and St Jude Children's Research Hospital) between August 1, 2019 and May 2, 2024. The Pain Buddy app was designed for child use, thus, only the child was randomized to an arm. These numbers reflect the revised protocol included in this record. The originally reported phases (1, 2, and RCADS sample) have been removed, thus no data is available for reporting.
Caregivers only completed outcome assessments. Although the protocol references additional samples, this group was never recruited separately. All children randomized to either arm of the study completed the RCADS measure.
Participant milestones
| Measure |
Parents of Children Randomized to Pain Buddy
Parents of children enrolled in the study were asked to complete surveys but did not use the Pain Buddy application.
|
Parents of Children Randomized to the Control Group
Parents of children enrolled in the study completed surveys but did not use the Pain Buddy application.
|
Pain Buddy
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
110
|
93
|
111
|
93
|
|
Overall Study
COMPLETED
|
75
|
85
|
75
|
85
|
|
Overall Study
NOT COMPLETED
|
35
|
8
|
36
|
8
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Parent sex is unknown/not collected from parents
Baseline characteristics by cohort
| Measure |
Pain Buddy
n=111 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=93 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
Parents of Children Randomized to Pain Buddy
n=110 Participants
Parents of children enrolled in the study completed surveys but did not use the Pain Buddy application.
|
Parents of Children Randomized to Control
n=92 Participants
Parents of children enrolled in the study completed surveys but did not use the mobile health application.
|
Total
n=406 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
12.73 years
STANDARD_DEVIATION 2.99 • n=111 Participants
|
11.74 years
STANDARD_DEVIATION 2.64 • n=93 Participants
|
41.06 years
STANDARD_DEVIATION 7.57 • n=110 Participants
|
40.59 years
STANDARD_DEVIATION 7.8 • n=92 Participants
|
26.51 years
STANDARD_DEVIATION 15.41 • n=406 Participants
|
|
Sex: Female, Male
Female
|
42 Participants
n=111 Participants • Parent sex is unknown/not collected from parents
|
47 Participants
n=93 Participants • Parent sex is unknown/not collected from parents
|
—
|
—
|
89 Participants
n=204 Participants • Parent sex is unknown/not collected from parents
|
|
Sex: Female, Male
Male
|
69 Participants
n=111 Participants • Parent sex is unknown/not collected from parents
|
46 Participants
n=93 Participants • Parent sex is unknown/not collected from parents
|
—
|
—
|
115 Participants
n=204 Participants • Parent sex is unknown/not collected from parents
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
31 Participants
n=111 Participants
|
23 Participants
n=93 Participants
|
27 Participants
n=110 Participants
|
23 Participants
n=92 Participants
|
104 Participants
n=406 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
80 Participants
n=111 Participants
|
70 Participants
n=93 Participants
|
83 Participants
n=110 Participants
|
69 Participants
n=92 Participants
|
302 Participants
n=406 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=111 Participants
|
0 Participants
n=93 Participants
|
0 Participants
n=110 Participants
|
0 Participants
n=92 Participants
|
0 Participants
n=406 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
3 Participants
n=111 Participants
|
1 Participants
n=93 Participants
|
4 Participants
n=110 Participants
|
1 Participants
n=92 Participants
|
9 Participants
n=406 Participants
|
|
Race (NIH/OMB)
Asian
|
20 Participants
n=111 Participants
|
17 Participants
n=93 Participants
|
25 Participants
n=110 Participants
|
17 Participants
n=92 Participants
|
79 Participants
n=406 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=111 Participants
|
0 Participants
n=93 Participants
|
0 Participants
n=110 Participants
|
0 Participants
n=92 Participants
|
0 Participants
n=406 Participants
|
|
Race (NIH/OMB)
Black or African American
|
11 Participants
n=111 Participants
|
9 Participants
n=93 Participants
|
9 Participants
n=110 Participants
|
9 Participants
n=92 Participants
|
38 Participants
n=406 Participants
|
|
Race (NIH/OMB)
White
|
77 Participants
n=111 Participants
|
66 Participants
n=93 Participants
|
72 Participants
n=110 Participants
|
65 Participants
n=92 Participants
|
280 Participants
n=406 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=111 Participants
|
0 Participants
n=93 Participants
|
0 Participants
n=110 Participants
|
0 Participants
n=92 Participants
|
0 Participants
n=406 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=111 Participants
|
0 Participants
n=93 Participants
|
0 Participants
n=110 Participants
|
0 Participants
n=92 Participants
|
0 Participants
n=406 Participants
|
|
Region of Enrollment
United States
|
111 participants
n=111 Participants
|
93 participants
n=93 Participants
|
110 participants
n=110 Participants
|
92 participants
n=92 Participants
|
204 participants
n=406 Participants
|
|
Visual Analog Scale
|
61.13 units on a scale
STANDARD_DEVIATION 22.24 • n=111 Participants • The visual analog scale is a continuous measure of patient self-reported pain severity. Thus, parent VAS was not collected.
|
64.18 units on a scale
STANDARD_DEVIATION 22.48 • n=93 Participants • The visual analog scale is a continuous measure of patient self-reported pain severity. Thus, parent VAS was not collected.
|
—
|
—
|
62.52 units on a scale
STANDARD_DEVIATION 22.35 • n=204 Participants • The visual analog scale is a continuous measure of patient self-reported pain severity. Thus, parent VAS was not collected.
|
PRIMARY outcome
Timeframe: Baseline and day 60Population: Phase one and phase two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure.
As part of the daily electronic Pain Buddy diary, children were administered the Memorial Symptoms Assessment Scale. Children 8-9 years of age received an 8-item instrument and were asked to report frequency (i.e. a very short time, a medium amount, almost all the time) severity (i.e. a little, a medium amount, very), and how distressful (i.e. not at all, a little, a medium amount, very) each symptom was. Children 10-18 years of age received a 30-item instrument and were asked to report how often (i.e. almost never, sometimes, a lot, almost always), how severe (i.e. slight, moderate, severe, very severe), and how distressful (i.e. not at all, a little bit, somewhat, quite a bit, very much) each symptom was. The items related to pain severity were used to calculate a 0-10 continuous score of self-reported pain severity for participants in each group. For this outcome, lower scores represent improvement in pain severity.
Outcome measures
| Measure |
Pain Buddy
n=111 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=93 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
Changes in Pain Severity Over Time
|
6.5 scores on a scale
Standard Error 0.585
|
4.08 scores on a scale
Standard Error 0.585
|
SECONDARY outcome
Timeframe: Baseline (T1)Population: Phase one and phase two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure.
Medication Attitude Questionnaire (MAQ) (parent self-report). This questionnaire was developed to examine attitudes about using pain medication for treating children's pain. The instrument consists of 16 items each rated on a seven-point Likert-type scale that ranges from strongly disagree to strongly agree. The factors were Appropriate-Use, Side-Effects (e.g., "Side effects are something to worry about when giving children pain medication"), and Avoidance (e.g., "Pain medication works best if saved for when the pain is quite bad"). Scores for the side effects scale range from 5-35. Scores for Avoidance range from 7-49. Scores for Appropriate Use range from 4-28 A total score reflective of misconceptions is calculated by summing all the subscales. The total score ranges from 16-112 with higher scores indicating more negative attitudes towards use of pain medication.
Outcome measures
| Measure |
Pain Buddy
n=109 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=92 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
Medication Attitude Questionnaire (MAQ) (Parent Self-report)
|
23.37 score on a scale
Standard Deviation 5.11
|
23.81 score on a scale
Standard Deviation 4.90
|
SECONDARY outcome
Timeframe: Baseline (T1), day 60 (T2), and day 180 (T3)Population: The number analyzed in one or more rows differs from the overall number analyzed due to attrition rates across time points, and missing data within measures that did not allow for calculation of scales. Additionally, phase one and two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure as part of the standard survey battery.
Perceived Stress Scale (PSS) (parent self-report) The PSS is a widely used 14-item self-report measure of perceived stress. Parents will be asked to rate statements such as "In the past month, how often have you been upset because of something that happened unexpectedly?" and "In the past month how often have you felt that things were going your way?" Subjects rate the items on a 5-point Likert-type scale. Seven items are reverse-keyed and items are summed to obtain the final score. Total scores range from 0-56. Higher scores reflect greater perceived stress. The PSS has been shown to have adequate reliability and validity. Completed at baseline, 60 days, and 6 month follow-up using REDCap
Outcome measures
| Measure |
Pain Buddy
n=109 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=92 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
Changes in Perceived Stress (Parent Self-report)
Parent T1- PSS total score
|
24.01 score on a scale
Standard Deviation 9.06
|
26.13 score on a scale
Standard Deviation 7.86
|
|
Changes in Perceived Stress (Parent Self-report)
Parent T3- PSS total score
|
21.60 score on a scale
Standard Deviation 9.07
|
22.05 score on a scale
Standard Deviation 10.13
|
|
Changes in Perceived Stress (Parent Self-report)
Parent T2- PSS total score
|
21.58 score on a scale
Standard Deviation 8.35
|
23.59 score on a scale
Standard Deviation 8.63
|
SECONDARY outcome
Timeframe: Baseline (T1)Population: Parent report of trait inventory. Phase one and two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure as part of the standard survey battery.
State-Trait Anxiety Inventory (STAI) (parent self-report). This is a widely used self-report anxiety assessment instrument for adults.The questionnaire contains two separate, 20-item, 4-point self-report rating scales for measuring trait and state anxiety. TOTAL scores are summed for situational and trait anxiety. Scores range from 20 to 80 each; higher scores denote higher levels of anxiety. For our purposes, only the one page Trait section of the questionnaire will be administered and utilized. Completed at baseline (T1) using REDCap. Scores from 20-37 indicate low anxiety, 38-44 indicate moderate anxiety, and 45-80 indicate high anxiety.
Outcome measures
| Measure |
Pain Buddy
n=95 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=81 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
State-Trait Anxiety Inventory (STAI) (Parent Self-report)
|
39.65 score on a scale
Standard Deviation 9.33
|
41.28 score on a scale
Standard Deviation 8.63
|
SECONDARY outcome
Timeframe: Baseline (T1) , day 60 (T2) , and day 180 (T3)Population: The number analyzed in one or more rows differs from the overall number analyzed due to attrition rates across time points, and missing data within measures that did not allow for calculation of total scores. Phase one and two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure as part of the standard survey battery.
The Revised Child Anxiety and Depression Scale (RCADS) -Child's self report on 47-item scale with subscales including separation anxiety, social phobia, generalized anxiety, panic disorder, obsessive compulsive disorder, and major depression. Items are rated on a 4-point Likert scale from 0 ("never") to 3 ("always"). Higher scores suggest higher levels of anxiety and depression. TOTAL Scores range from 0-141.
Outcome measures
| Measure |
Pain Buddy
n=110 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=92 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
Changes in Children's Anxiety and Depression Assessed Using the Revised Child Anxiety and Depression Scale (RCADS)
Child T1- RCADS total score
|
27.52 score on a scale
Standard Deviation 15.55
|
29.18 score on a scale
Standard Deviation 13.29
|
|
Changes in Children's Anxiety and Depression Assessed Using the Revised Child Anxiety and Depression Scale (RCADS)
Child T2- RCADS total score
|
22.28 score on a scale
Standard Deviation 18.30
|
26.13 score on a scale
Standard Deviation 15.44
|
|
Changes in Children's Anxiety and Depression Assessed Using the Revised Child Anxiety and Depression Scale (RCADS)
Child T3 - RCADS total score
|
22.39 score on a scale
Standard Deviation 18.35
|
23.62 score on a scale
Standard Deviation 16.09
|
SECONDARY outcome
Timeframe: Baseline (T1) , day 60 (T2) , and day 180 (T3)Population: The number analyzed in one or more rows differs from the overall number analyzed due to attrition rates across time points, and missing data within measures that did not allow for calculation of scales. Additionally, phase one and two participants were not part of the current IRB number (181088) and the "RCADS sample group" was not recruited as a separate arm under this protocol. All children randomized to Pain Buddy or control completed the RCADS measure as part of the standard survey battery.
Children and parents are asked to report on the child's health related quality of life. The measure incorporates a generic (divided into 4 categories: physical, emotional, social and school), cancer (divided into 8 categories: pain \& hurt, nausea, procedural anxiety, treatment anxiety, cognitive problems, perceived physical appearance and communication), and fatigue module (divided into 3 categories: general fatigue, sleep/rest fatigue, cognitive fatigue). Higher scores on the scale suggest a better health related quality of life. Questions are asked on a 5-point likert scale ranging from 0=never to 4=almost always. Scores are transformed from 0-100. TOTAL scores for each module range from 0-100 on the PedsQL.
Outcome measures
| Measure |
Pain Buddy
n=111 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms. The skills will be taught through the electronic tablet. Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Control
n=92 Participants
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
|---|---|---|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent PedsQL Fatigue T1
|
64.17 score on a scale
Standard Deviation 18.02
|
65.16 score on a scale
Standard Deviation 17.89
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T1- PedsQL Cancer
|
66.62 score on a scale
Standard Deviation 16.08
|
65.51 score on a scale
Standard Deviation 16.16
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T1- PedsQL General
|
62.58 score on a scale
Standard Deviation 17.98
|
61.22 score on a scale
Standard Deviation 16.65
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T1- PedsQL Fatigue
|
66.92 score on a scale
Standard Deviation 18.15
|
65.17 score on a scale
Standard Deviation 19.01
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T1- PedsQL Cancer
|
70.57 score on a scale
Standard Deviation 15.51
|
70.69 score on a scale
Standard Deviation 15.77
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T1- PedsQL General
|
69.75 score on a scale
Standard Deviation 16.40
|
68.83 score on a scale
Standard Deviation 16.06
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T2- PedsQL Fatigue
|
66.87 score on a scale
Standard Deviation 20.67
|
67.49 score on a scale
Standard Deviation 29.91
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T2- PedsQL Cancer
|
68.43 score on a scale
Standard Deviation 18.72
|
66.79 score on a scale
Standard Deviation 15.44
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T2- PedsQL General
|
64.36 score on a scale
Standard Deviation 19.82
|
63.80 score on a scale
Standard Deviation 17.43
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T2- PedsQL Fatigue
|
72.41 score on a scale
Standard Deviation 21.82
|
70.37 score on a scale
Standard Deviation 19.46
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T2- PedsQL General
|
73.12 score on a scale
Standard Deviation 17.23
|
72.01 score on a scale
Standard Deviation 16.94
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T3- PedsQL Fatigue
|
71.05 score on a scale
Standard Deviation 21.09
|
70.07 score on a scale
Standard Deviation 20.92
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T3- PedsQL Cancer
|
69.83 score on a scale
Standard Deviation 18.55
|
66.18 score on a scale
Standard Deviation 19.36
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Parent T3- PedsQL General
|
68.30 score on a scale
Standard Deviation 19.93
|
66.18 score on a scale
Standard Deviation 19.36
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T3- PedsQL Fatigue
|
75.33 score on a scale
Standard Deviation 19.85
|
71.12 score on a scale
Standard Deviation 21.28
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T3- PedsQL Cancer
|
77.57 score on a scale
Standard Deviation 17.59
|
76.41 score on a scale
Standard Deviation 15.15
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T3- PedsQL General
|
75.74 score on a scale
Standard Deviation 17.43
|
73.71 score on a scale
Standard Deviation 17.48
|
|
Changes in Children's Quality of Life Since Using Pain Buddy is Assessed Using the Pediatric Quality of Life Inventory (Child Self-report, Ages 8-12, 13-18; Parent Report Child Ages 8-12, 13-18)
Child T2- PedsQL Cancer
|
75.91 score on a scale
Standard Deviation 17.09
|
72.92 score on a scale
Standard Deviation 15.01
|
Adverse Events
Pain Buddy
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place